Search Within

Pere Barba Sunol

Formats
  1. Meeting Abstract (11)
  2. Journal Article (5)
Groups
  1. Bone Marrow Transplant (14)
  2. Center for Hematologic Malignancies (14)
  3. Department of Medicine (14)
  4. Hematologic Malignancies, Division of (14)
  5. Biostatistics Service (13)
  6. Epidemiology and Biostatistics (13)

More Groups

People
  1. Miguel-Angel Perales (14)
  2. Sean Devlin (13)
  3. Molly Maloy (11)
  4. Ann Jakubowski (9)
  5. Esperanza Papadopoulos (9)
  6. Hugo Castro-Malaspina (9)

More People

Years
  1. 2018 (2)
  2. 2017 (4)
  3. 2016 (10)
Publications
  1. Biology of Blood and Marrow Transplantation (10)
  2. Bone Marrow Transplantation (5)
  3. Transplant Infectious Disease (1)
Publishers
  1. Elsevier Inc. (10)
  2. Nature Publishing Group (5)
  3. Wiley Blackwell (1)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Myeloablative conditioning and CD34+ selection results in higher chronic-GVHD free/relapse free-survival compared to reduced-intensity conditioning and unmodified graft in patients with AML and MDS > 50 years receiving HLA-matched allogeneic HCT
    Meeting Abstract

    Barba, P.; Martino, R.; Zhou, Q.; Cho, C.; Castro-Malaspina, H.; Devlin, S.; Esquirol, A.; Giralt, S.; Jakubowski, A.; Lopez-Corral, L.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Sirolimus, tacrolimus and low-dose methotrexate as GVHD prophylaxis is safe and associated with promising results in patients receiving reduced-toxicity allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Avila, A. M.; Barba, P.; Cho, C.; Devlin, S.; Ceberio, I.; Ponce, D.; Maloy, M.; Perales, M. A.
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted (TCD) grafts for allogeneic hematopoietic cell transplantation (Allo-HSCT) is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Dierov, D.; Herman, D.; Mosesso, K.; Nieves, J.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Systematic anti-mold prophylaxis results in very low incidence of invasive fungal infections in patients undergoing allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rosillo, C.; Barba, P.; Huang, Y. T.; Avila, A. M.; Montoro, J.; Maloy, M.; Papanicolaou, G. A.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save